Organogenesis Holdings (ORGO) Current Assets (2015 - 2026)

Organogenesis Holdings' Current Assets history runs 12 years deep, the most recent figure standing at $268.5 million for Q1 2026.

• In Q1 2026, Current Assets changed 0.13% year-over-year to $268.5 million; the TTM figure through Mar 2026 stood at $268.5 million (changed 0.13% YoY), while the FY2025 annual figure was $362.2 million, up 26.67% from the prior year.
• Current Assets was $268.5 million for Q1 2026 at Organogenesis Holdings, down from $362.2 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $362.2 million in Q4 2025 to a low of $216.4 million in Q2 2023.
• Historically, Current Assets has averaged $248.9 million across 5 years, with a median of $231.5 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Assets declined 6.52% in 2023, then grew 27.06% in 2024.
• A 5-year view of Current Assets shows it stood at $222.6 million in 2022, then rose by 1.09% to $225.0 million in 2023, then advanced by 27.06% to $285.9 million in 2024, then gained by 26.67% to $362.2 million in 2025, then retreated by 25.87% to $268.5 million in 2026.
• The last three Current Assets figures came in at $268.5 million (Q1 2026), $362.2 million (Q4 2025), and $299.7 million (Q3 2025), per Business Quant data.